Newsfiscal.ai
INmune Bio, Inc. Announces Pricing of $4.50 Million Registered Direct Offering and Concurrent Private Placement
· Published
Article summary
INmune Bio, Inc. has priced a registered direct offering and a concurrent private placement for gross proceeds of approximately $4.50 million.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…